Monoclonal antibodies: formulations of marketed products and recent advances in novel delivery system-Reference-Cited by-同舟云学术

Monoclonal antibodies: formulations of marketed products and recent advances in novel delivery system

Published:2017-01-22 Issue:4 Volume:43 Page:519-530
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Cui Yanan¹,Cui Ping²,Chen Binlong³⁴,Li Suxin³⁴,Guan Hua¹

Affiliation:

1. School of Pharmacy, Jining Medicinal College, Jining, China;

2. Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, Tianjin, National Clinical Research Centre of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China;

3. State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China;

4. Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China

Funder

Major Scientific Project of Jining Medical College

Science and Technology Program of Shandong Colleges and Universities

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2017.1278768

Reference104 articles.

2. Clinical development success rates for investigational drugs

3. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies